Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases (IBDs) are complex, multifactorial disorders characterized by chronic relapsing intestinal inflammation. Although etiology remains largely unknown, recent research has suggested that genetic factors, environment, microbiota, and immune response are involved in the pathogenesis. Epidemiological evidence for a genetic contribution is defined: 15% of patients with Crohn's Disease (CD) have an affected family member with IBD, and twin studies for CD have shown 50% concordance in monozygotic twins compared to <10% in dizygotics. The most recent and largest genetic association studies, which employed genome-wide association data for over 75,000 patients and controls, identified 163 susceptibility loci for IBD. More recently, a trans-ethnic analysis, including over 20,000 individuals, identified an additional 38 new IBD loci. Although most cases are correlated with polygenic contribution toward genetic susceptibility, there is a spectrum of rare genetic disorders that can contribute to early-onset IBD (before 5 years) or very early onset IBD (before 2 years). Genetic variants that cause these disorders have a wide effect on gene function. These variants are so rare in allele frequency that the genetic signals are not detected in genome-wide association studies of patients with IBD. With recent advances in sequencing techniques, ~50 genetic disorders have been identified and associated with IBD-like immunopathology. Monogenic defects have been found to alter intestinal immune homeostasis through many mechanisms. Candidate gene resequencing should be carried out in early-onset patients in clinical practice. The evidence that genetic factors contribute in small part to disease pathogenesis confirms the important role of microbial and environmental factors. Epigenetic factors can mediate interactions between environment and genome. Epigenetic mechanisms could affect development and progression of IBD. Epigenomics is an emerging field, and future studies could provide new insight into the pathogenesis of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,507
Cooney, R., Baker, J., Brain, O., Danis, B., Pichulik, T., Allan, P., Ferguson, D. J. P., Campbell, B. J., Jewell, D., & Simmons, A. (2010) · Nature Medicine · doi:10.1038/nm.2069 · Cited by 1,047
The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease
Uhlig, H. H., Schwerd, T., Koletzko, S., Shah, N., Kammermeier, J., Elkadri, A., Ouahed, J., Wilson, D. C., Travis, S. P., Turner, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.023 · Cited by 715
Worthey, E. A., Mayer, A. N., Syverson, G. D., Helbling, D., Bonacci, B. B., Decker, B., Serpe, J. M., Dasu, T., Tschannen, M. R., Veith, R. L., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182088158 · Cited by 711
Genomic analysis of human microRNA transcripts
Saini, H. K., Griffiths-Jones, S., & Enright, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703890104 · Cited by 554
Disease gene identification strategies for exome sequencing
Gilissen, C., Hoischen, A., Brunner, H. G., & Veltman, J. A. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.258 · Cited by 460
Genetics of Inflammatory Bowel Diseases
McGovern, D. P. B., Kugathasan, S., & Cho, J. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.001 · Cited by 431
Recent Insights Into the Genetics of Inflammatory Bowel Disease
Cho, J. H., & Brant, S. R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.046 · Cited by 425
Cited by
The role of inflammation and genetics in periodontal disease
Loos, B. G., & Van Dyke, T. E. (2020) · Periodontology 2000 · doi:10.1111/prd.12297 · Cited by 612
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
Saez, A., Herrero-Fernandez, B., Gomez-Bris, R., Sánchez-Martinez, H., & Gonzalez-Granado, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021526 · Cited by 580
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease
Weingarden, A. R., & Vaughn, B. P. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1290757 · Cited by 463
Nutrition, IBD and Gut Microbiota: A Review
Mentella, M. C., Scaldaferri, F., Pizzoferrato, M., Gasbarrini, A., & Miggiano, G. A. D. (2020) · Nutrients · doi:10.3390/nu12040944 · Cited by 340
Tong, L.-C., Wang, Y., Wang, Z.-B., Liu, W.-Y., Sun, S., Li, L., Su, D.-F., & Zhang, L.-C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00253 · Cited by 331
Dysbiosis of gut microbiota in promoting the development of colorectal cancer
Zou, S., Fang, L., & Lee, M.-H. (2018) · Gastroenterology Report · doi:10.1093/gastro/gox031 · Cited by 280
Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S., & Amedei, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02754 · Cited by 204
“The association with the host genetic susceptibility (NOD2, TLR4, CARD9, ATG16L1, IL23R polymorphisms), immunological abnormalities, the key role of gut microbiota (GM) and its produced metabolites, and other environmental factors, have been recently investigated (4).”
BackgroundEpithelial cell extrusion: Pathways and pathologies
Gudipaty, S. A., & Rosenblatt, J. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.05.010 · Cited by 167
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair
Farr, L., Ghosh, S., & Moonah, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01273 · Cited by 166
Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease
Guo, X., Huang, C., Xu, J., Xu, H., Liu, L., Zhao, H., Wang, J., Huang, W., Peng, W., Chen, Y., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.818902 · Cited by 165
“Thus, microbial treatment by restoring intestinal flora in patients with IBD has been attempted by an increasing number of scholars (110).”
BackgroundCytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases
Chen, M. L., & Sundrud, M. S. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000714 · Cited by 158
“Several key concepts in IBD pathogenesis have emerged over the past decade, which have been summarized in this article, and each concept is reviewed elsewhere in more detail.(2,6,7) First, despite their common clinical classification (as IBD), UC and CD are fundamentally different diseases with unique pathophysiologic…”
BackgroundInfluentialda Silva, T. F., Glória, R. D. A., Americo, M. F., Freitas, A. D. S., de Jesus, L. C. L., Barroso, F. A. L., Laguna, J. G., Coelho-Rocha, N. D., Tavares, L. M., le Loir, Y., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10247-x · Cited by 117
“The main risk factors associated with these diseases’ etiology are family history, genetic susceptibility, environmental factors (e.g., cigarette smoking, stress), intestinal dysbiosis, and altered immune response [200–202].”
Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease
Jergens, A. E., Parvinroo, S., Kopper, J., & Wannemuehler, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.669913 · Cited by 63
Yin, M., Yan, X., Weng, W., Yang, Y., Gao, R., Liu, M., Pan, C., Zhu, Q., Li, H., Wei, Q., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487027 · Cited by 58
Cushing, K. C., Chiplunker, A., Li, A., Sung, Y. J., Geisman, T., Chen, L.-S., Cresci, S., & Gutierrez, A. M. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx094 · Cited by 9
Metadata
- Authors
- Loddo, I., & Romano, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2015-11-02
- Volume
- 6
- Pages
- 551-551
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2194307286
- Cited by
- 449
- References
- 26
- FWCI
- 20.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.